Imlunestrant-Based Therapy May Improve Survival Without Progression in Advanced Breast Cancer
Local Recurrence Lowered With Immediate Surgery in Elderly Patients With Breast Cancer
Lynparza Continues to Benefit in BRCA1/2+, HER2- Breast Cancer
Enhertu Improves Progression-Free Survival in HR+, HER2-Low/Ultralow Metastatic Breast Cancer